Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation

Med Hypotheses. 2016 Oct:95:34. doi: 10.1016/j.mehy.2016.08.006. Epub 2016 Aug 16.

Affiliations

¹ Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.
² Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece. Electronic address: [email protected].

PMID: 27692162
DOI: 10.1016/j.mehy.2016.08.006

No abstract available

Publication types

Letter

MeSH terms

Animals
Anti-Inflammatory Agents / therapeutic use
CD4-Positive T-Lymphocytes / cytology
CD8-Positive T-Lymphocytes / cytology
Colchicine / therapeutic use*
Fibrosis / drug therapy*
Humans
Inflammation / drug therapy*
Metabolic Syndrome / drug therapy*
Metabolic Syndrome / metabolism
Models, Theoretical
Obesity
T-Lymphocytes, Cytotoxic / cytology

Substances

Anti-Inflammatory Agents
Colchicine